Maze Therapeutics, Inc. (MAZE)
32.58
+0.13
(+0.40%)
USD |
NASDAQ |
Oct 21, 16:00
32.53
-0.05
(-0.15%)
After-Hours: 20:00
Maze Therapeutics Market Cap : 1.808B for Oct. 21, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 21, 2026 | 1.808B |
| October 20, 2026 | 1.801B |
| October 19, 2026 | 1.648B |
| October 16, 2026 | 1.528B |
| October 15, 2026 | 1.525B |
| October 14, 2026 | 1.456B |
| October 13, 2026 | 1.480B |
| October 12, 2026 | 1.537B |
| October 09, 2026 | 1.505B |
| October 08, 2026 | 1.436B |
| October 07, 2026 | 1.457B |
| October 06, 2026 | 1.467B |
| October 05, 2026 | 1.467B |
| October 02, 2026 | 1.467B |
| October 01, 2026 | 1.479B |
| September 30, 2026 | 1.509B |
| September 29, 2026 | 1.500B |
| September 28, 2026 | 1.490B |
| September 25, 2026 | 1.446B |
| September 24, 2026 | 1.455B |
| September 23, 2026 | 1.559B |
| September 22, 2026 | 1.575B |
| September 21, 2026 | 1.243B |
| September 18, 2026 | 1.250B |
| September 17, 2026 | 1.301B |
| Date | Value |
|---|---|
| September 16, 2026 | 1.327B |
| September 15, 2026 | 1.345B |
| September 14, 2026 | 1.369B |
| September 11, 2026 | 1.365B |
| September 10, 2026 | 1.378B |
| September 09, 2026 | 1.364B |
| September 08, 2026 | 1.464B |
| September 04, 2026 | 1.455B |
| September 03, 2026 | 1.436B |
| September 02, 2026 | 1.483B |
| September 01, 2026 | 1.473B |
| August 31, 2026 | 1.475B |
| August 28, 2026 | 1.523B |
| August 27, 2026 | 1.587B |
| August 26, 2026 | 1.642B |
| August 25, 2026 | 1.688B |
| August 24, 2026 | 1.643B |
| August 21, 2026 | 1.634B |
| August 20, 2026 | 1.606B |
| August 19, 2026 | 1.651B |
| August 18, 2026 | 1.617B |
| August 17, 2026 | 1.551B |
| August 14, 2026 | 1.509B |
| August 13, 2026 | 1.536B |
| August 12, 2026 | 1.528B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.660B |
| Corcept Therapeutics, Inc. | 12.55B |
| Veru, Inc. | 39.22M |
| Johnson & Johnson | 620.79B |
| Eli Lilly & Co. | 1.196T |
Market Cap Related Metrics
| PS Ratio | 85.65 |
| PEG Ratio | -0.2548 |
| Price to Book Value | 3.991 |
| Price | 32.58 |
| Earnings Yield | -7.78% |
| PEGY Ratio | -0.2548 |